Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Carl June
CAR T immunotherapy
Lev Kats
myeloma and epigenetics
Eugenio Morelli
Myeloma
Alfred Garfall
myeloma immunotherapy
F. Lennie Wong
Equity in Access
Armin Rashidi
gut bacteria and transplant success
Jing Yang
Myeloma
Christopher Flowers
clinical trial access
Noemí Puig Morón
Myeloma
Caroline Arber
myeloma CAR-T
Mala Shanmugam
myeloma
Matteo Bellone
Smoldering multiple myeloma
Sham Mailankody
Myeloma immunotherapy clinical trials
Jun Qi
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Brian Walker
smoldering myeloma, MGUS
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
William Matsui
Myeloma
Peter Croucher
Multiple Myeloma
Jonathan Licht
DNA biology, myeloma
Bruno Paiva
smoldering myeloma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Urvi Shah
Diet and myeloma
Fenghuang Zhan
Myeloma and bone disease
Tanya Siddiqi
clinical trial access
Jing Fu
myeloma
John Leonard
lymphoma research
Lawrence Boise
CART and myeloma
Jianhua Yu
myeloma immunotherapy
Ruben Carrasco
Myeloma
Siegfried Janz
Myeloma immunotherapy
Simona Colla
Myeloma biology
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM
Suzanne Lentzsch
Myeloma
Nizar Bahlis
Myeloma immunotherapy
Paul Beavis
immunotherapy in myeloma
Madhav Dhodapkar
multiple myeloma immunotherapy
Qing Yi
Novel CAR-T
Michaela Reagan
Multiple Myeloma
Ricky Johnstone
lymphoma and myeloma